CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- 4 Open-market sale Chief Medical Officer sold 5,958 shares at $200.00 ($1,191,600)
- 4/A Open-market sale Chief Science Officer sold 2,835 shares at $140.00 ($396,900)
- 4 Open-market sale Chief Operating Officer sold 3,670 shares at $72.22 ($265,029)
- 4 Open-market sale Executive Chairman sold 7,928 shares at $134.12 ($1,063,303)
- 4 Open-market sale Chief Science Officer sold 3,892 shares at $140.00 ($544,880)
- 4 Open-market sale Chief Commercial Officer sold 6,151 shares at an average $130.97 ($805,589)
- 4 Open-market sale Chief Financial Officer sold 765 shares at $130.81 ($100,067)
- 4 Open-market sale General Counsel sold 2,404 shares at $130.81 ($314,458)
- 4 Open-market sale Chief Development Officer sold 765 shares at $130.81 ($100,067)
- 4 Open-market sale Chief Operating Officer sold 3,004 shares at $130.81 ($392,941)
- 4 Open-market sale Chief Commercial Officer sold 4,550 shares at $131.53 ($598,462)
- 4 Open-market sale Chief Medical Officer sold 2,918 shares at $131.53 ($383,805)
- 4 Open-market sale Chief Operating Officer sold 3,854 shares at $137.55 ($530,133)
- 4 Open-market sale General Counsel sold 3,084 shares at $137.55 ($424,217)
- 4 Open-market sale Chief Development Officer sold 567 shares at $137.55 ($77,993)
- 4 Open-market sale Chief Financial Officer sold 567 shares at $137.55 ($77,993)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 16 of 39 · 780 filings